Checking infection levels after deworming treatment in Uganda
Treatments studied
Part of Infections clinical trials.
This study checks how well deworming treatment works by testing stool samples from school children in Uganda before and after treatment. It helps see if the infection is reduced or gone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Children aged 5 to 14 years who attend a participating school
- A parent or guardian must agree, and the child must also agree to take part
- Able to provide stool samples before treatment and again at 3 weeks and 3 months after treatment
- No use of deworming medication in the 4 weeks before the study starts
- No known allergy to the study drugs (albendazole, mebendazole, or ivermectin)
- Not currently participating in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different combinations of medicines to treat whipworm infection in children. It aims to find the best way to clear the infection and improve children's health.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
This study tests a single dose of a new medicine, emodepside, against a standard deworming medicine, albendazole, for treating whipworm infections. It aims to see which is more effective and safe.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
Hear when a new Ascariasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.